ARMATA PHARMACEUTICALS, INC. (ARMP) Operating income 2016–2025
ARMATA PHARMACEUTICALS, INC. (ARMP) annual operating income history from SEC filings — each fiscal year as reported.
-$36.6MFY2025 · since FY2016: -$23.4M → -$36.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$36.6M | +13.7% |
| FY2024 | -$42.4M | -3.8% |
| FY2023 | -$40.9M | -10.7% |
| FY2022 | -$36.9M | -55.1% |
| FY2021 | -$23.8M | -10.4% |
| FY2020 | -$21.6M | -9.3% |
| FY2019 | -$19.8M | -11.9% |
| FY2018 | -$17.7M | -9.3% |
| FY2017 | -$16.2M | +30.9% |
| FY2016 | -$23.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ARMP financial trends
ARMP RevenueARMP Net incomeARMP Net marginARMP Gross profitARMP Gross marginARMP Operating marginARMP Operating cash flowARMP Free cash flowARMP Capital expendituresARMP Return on equityARMP Stock buybacksARMP Dividends paidARMP Total assetsARMP Total liabilitiesARMP Shareholders’ equityARMP overview →